Kelyniam Global Inc. Embraces a Unique Investor Engagement Opportunity
The Company invites individual and institutional investors, along with advisors and analysts, to participate in an exciting online event hosted on VirtualInvestorConferences.com.
Details of the Virtual Forum
Kelyniam Global Inc. (OTC: KLYG), known for its custom cranial implants, has announced that its CFO, Terrance Kurtenbach, will present live at the Life Sciences Virtual Investor Forum. This interactive opportunity will allow attendees to engage directly with the company on key initiatives and innovations.
Event Schedule
Mark your calendars for this important presentation. The date is set for September 18, and the session will begin at 10:00 AM EDT. This event promises to be a key moment for investors seeking insights into the company’s future and product developments.
1x1 Meetings for Interested Parties
Following the forum, Kelyniam’s management team will be available for one-on-one meetings on September 18 PM, 19, and 22. Interested participants are encouraged to pre-register and schedule their slots using the provided event link.
Interactive Presentation Experience
This live online event is designed for investor engagement, allowing participants to pose real-time questions to the company. For those who cannot attend the live presentation, an archived version will be accessible post-event, ensuring everyone can stay informed.
Pre-Registration is Recommended
Potential attendees are advised to pre-register and perform an online system check to facilitate a smooth experience. This will ensure you receive updates and can engage fully during the event.
Kelyniam’s Product Innovations
Kelyniam Global Inc. is not just participating in the forum; they are bringing significant sales momentum and enhancements to their product lines. The Company's flagship products, including the CustomizedBone™ implant, are set to transform the cranial implant space, particularly appealing to surgeons seeking osteointegrative benefits.
Collaboration and Growth
In partnership with Finceramica Spa of Italy for their hydroxyapatite implants and utilizing products from Osteopore, Kelyniam is poised to establish itself as a leader in regenerative solutions within the U.S. surgical community.
About Kelyniam Global Inc.
Kelyniam specializes in the rapid production of custom prosthetics, utilizing cutting-edge computer-aided design and manufacturing technologies. Their focus is on developing, manufacturing, and distributing cranial implants tailored to individual patient needs.
Company Commitment to Improvement
Kelyniam works closely with surgeons, health systems, and payors to enhance clinical and financial outcomes, reflecting their dedication to improving healthcare delivery.
Frequently Asked Questions
What is Kelyniam Global Inc. known for?
Kelyniam Global Inc. specializes in custom cranial implants and advanced prosthetics utilizing modern manufacturing techniques.
When is Kelyniam’s presentation at the forum?
The presentation is scheduled for September 18 at 10:00 AM EDT.
Who will be presenting on behalf of Kelyniam?
Terrance Kurtenbach, the CFO, will represent Kelyniam during the presentation.
How can investors engage with Kelyniam during the event?
Investors can engage in real-time Q&A sessions during the live presentation.
Will there be a recording of the forum?
Yes, an archived version of the event will be made available after the live presentation.
